Faculty Information - MORI Fumiaki

（Last updated : 2026-07-21 22:10:00）

MORI Fumiaki
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Cardiology

Position Assistant Professor

■ Published papers

1.	Original article	Prognostic Utility of the BCIS-CHIP Score in Imaging-Guided Percutaneous Coronary Intervention. 2026/06
2.	Original article	Elevated Cystatin-C Levels Are Associated with Increased Mortality in Acute Coronary Syndrome Patients: An HIJ-PROPER Sub-Analysis. 2022
3.	Original article	Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome 2021/04
4.	Original article	Polyunsaturated Fatty Acid Impact on Clinical Outcomes in Acute Coronary Syndrome Patients With Dyslipidemia: Subanalysis of HIJ-PROPER. 2019/08
5.	Original article	Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan. 2019/06
6.	Original article	Safety and Efficacy of Low-Dose Prasugrel as Part of Triple Therapy With Aspirin and Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention - From the TWMU-AF PCI Registry. 2019/04
7.	Original article	PSGL-1 expressing CD4 T cells contribute plaque instability in acute coronary syndrome. 2018/05
8.	Original article	Differences in hemodynamic responses between intravenous carperitide and nicorandil in patients with acute heart failure syndromes 2013/05
9.	Original article	Efficacy of paclitaxel-eluting stent implantation in hemodialysis patients. 2011/11
10.	Other	The efficacy of Embolic Protection During Renal Artery Stenting 2011/08
11.	Other	Angiographic Outcomes Following Percutaneous Coronary Intervention with Paclitaxel-eluting Stents versus Sirolimus-eluting Stents in Hemodialysis Patients 2010
12.	Other	Comparison of angiographic outcomes after paclitaxel- and sirolimus- eluting stents implantation in chronic total occulusions 2010
13.	Other	Comparison of Anigographic Outcomes after Paclitaxel- and Sirolimus- eluting Stents Implantation in Diabetic Patients 2010
14.	Other	Comparison of Diabetic and Non-diabetic Patients after Paclitaxel-eluting Stent Implantation 2010
15.	Other	Comparison of diabetic and non-diabetic patients after paclitaxel-eluting stent implantation 2010
16.	Original article	Effect of amlodipine + candesartan on cardiovascular events in hypertensive patients with coronary artery disease (from The Heart Institute of Japan Candesartan Randomized Trial for Evaluation in Coronary Artery Disease [HIJ-CREATE] Study) 2010
17.	Other	Efficacy of the Combination of Amlodipine and ARB in Hypertensive Patients with Coronary Artery Disease,CAD 2010
18.	Other	FRS1 Indication and Pitfalls of DES: Long-term Clinical and Angiographic Outcomes after Sirolimus-Eluting Stent Implantation in Left Main Coronary Artery: From HIJ-DES Registry 2010
19.	Original article	Impact of anticoagulant therapy with dual antiplatelet therapy on prognosis after treatment with drug-eluting coronary stents 2010
20.	Other	PSGL-1expressing CD4 T cell in atherosclerotic plaque 2010
21.	Other	Risk Stratification of Patients with Non-ST Elevation Acute Coronary Syndromes by Assessing Global Longitudinal 2D Strain at Rest 2010
22.	Other	Role of PSGL-1 Expressing CD4 T Cells in Plaque Instability 2010
23.	Other	The Impact of Paclitaxel-Eluting Stent on Small Vessels in Patients with Diabetes 2010
Display 5 items
Display all(23)

■ Academic conference presentation

1.	Predictors for Thrombotic and Bleeding Events in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: from TWMU-AF PCI Registry （Speech，General） 2019/09/20
2.	Antithrombotic Therapy in Patients with Atrial Fibrillation and Hemodialysis Undergoing Percutaneous Coronary Intervention -Results from a Multicenter Registry （Speech，General） 2018/03/25
3.	Safety and Efficacy of Prasugrel Combined with Oral Anticoagulation for the Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention （Speech，General） 2018/03/24
4.	Clinical Utility of PARIS Score for the Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Multi-center Registry （Speech，General） 2017/03/17
5.	Maintenance Antithrombotic Therapy and Long-term Prognosis in Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention -1 year Landmark Analysis- （Speech，General） 2015/04/26
6.	Antithrombotic Therapy in Atrial Fibrillation Patients with Chronic Kidney Disease Undergoing Percutaneous Coronary Intervention-From Multicenter Cohort Study- （Speech，General） 2015/04/25
7.	The Impact of Renal Function and Diabetes on 1-year Outcomes in Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents （Poster notice，General） 2014/03/23
8.	The Impact of Hemodialysis and Insulin on 1-year Outcomes in Diabetic Patients Undergoing Percutaneous Coronary Intervention with Drug-eluting Stents （Poster notice，General） 2014/03/21
9.	Five cases required revascularization with critical hand ischemia （Speech，General） 2012/07/14
10.	Efficacy of balloon expandable stent implantation for common iliac artery lesions treated with endovascular therapy （Speech，General） 2012/07/12
11.	PSGL-1 Expressing CD4+ T-cells in Acute Coronary Syndrome （Poster notice，General） 2012/03/27
12.	The Efficacy of Embolic Protection during Renal Artery Stenting （Speech，General） 2012/03/17
13.	Direct Comparison between Ischemic Metabolism and Regional Wall Motion Dynamics in Non- ST Segment Elevation Acute Coronary Syndrome （Poster notice，General） 2012/03/16
14.	PSGL-1 Expressing CD4 T cells Contribute Plaque Instability in ACS （Poster notice，General） 2011/11
15.	The efficacy of Embolic Protection During Renal Artery Stenting （Panelist at Symposium/Workshop (Other)） 2011/09/24
16.	The efficacy of Embolic Protection During Renal Artery Stenting 2011/09
17.	The Differences of Hemodynamic Response Between Nicorandil and Carperitide in Patients with Acute Decompensated Heart Failure （Poster notice，General） 2011/08/30
18.	PSGL-1 expressing CD4 T cells in plaque instability （Speech，General） 2011/08
19.	Comparison of angiographic outcomes after paclitaxel- and sirolimus- eluting stents implantation in chronic total occulusions （General） 2010/08
20.	Comparison of diabetic and non-diabetic patients after paclitaxel-eluting stent implantation （General） 2010/08
21.	Heart Failure Etiology and Hemodynamic Response to Nicorandil in Patients With Acute Heart Failure Syndromes （Speech，General） 2010/08
22.	Efficacy of paclitaxel-eluting stents implantation in Japanese patients wqith hemodialysis （General） 2009/06
23.	Insulin treatments overweigh the beneficial effect of sirolimus eluting stent （General） 2009/06
24.	Middle term follow up result of sirorimus eluting stent from muticenter trial(The HIJ-DES registry) （General） 2009/06
25.	Clinical Evidence of DES Era Influence of the Early Ticlopidine Discontinuation on Clinical Outcomes following Sirolimmus-Eluting Stent Implantation) （General） 2009/03
26.	Insulin Treatments Overweigh the Beneficial Effect of Sirolimus Eluting Stent) （General） 2009/03
27.	Prognostic Factors in Patients with Coronary Artery Disease Treated with Sirolimus-eluting Stent: The HIJ/DES registry. Plenary Session1 Current Status and Future Perspective of Drug Eluting Stents. 2009/03
Display 5 items
Display all(27)

■ Education

Faculty of Medicine, Kumamoto University, Graduated,